Testosterone Transdermal System Articles
Watson's 3rd-qtr 2007 revenue hits $594.7M
19 November 2007
Pharmacia & Paladin sign Canadian distribution deal
28 January 2002
Paladin acquires hyperthyroid drug from Merck Frosst
3 September 2001
Unimed files NDA for Androgel in USA
6 May 1999
Alza and Pharmagenesis launch Testoderm
15 October 1998
Alza's Testosterone Patch Approved
5 January 1998
US 2nd Qtr Corporate Results Round-Up
7 August 1997
SB Launches Androderm One-Patch In USA
19 June 1997
Alza To License Testosterone Product From Therapeutic Discovery Corp
10 February 1997
TheraTech Files sNDA For Androderm
4 November 1996
US Corporate Quarterly Results Round-Up
13 May 1996
TheraTech's ATMOS Cleared In Sweden
15 April 1996
US Corporate Results Round-Up
26 February 1996
TheraTech/Solvay Collaborate On New HRT
6 November 1995
SmithKline Beecham Unveils Power Pipeline
9 October 1995
SB Expands Rights To Testosterone Patch
5 December 1994
Showing 1-17 of 17 articles
- 1
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
